Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF12A
NM
Basal B
2-deoxyglucose
12949.177
uM
1068.11960
999.58210
0.1328 0.1289 4.4961 0.1401
0.8220
1.7727
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
10473.138
uM
inf
1.19780
0.7189 0.7475 4.9965 0.0394
0.9219
1.2872
CAMA-1
HR+
Luminal
Glycyl-H-1152
ROCK2
12070.16
uM
1.30120
1.15090
0.2168 0.2294 4.9999 0.2666
0.9242
0.8453
HCC1806
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7830.016
uM
inf
inf
0.2581 0.2581 0.0000 0.1910
0.3538
2.0313
HCC1806
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7829.016
uM
13.43190
18.22980
-0.8442 -0.8456 3.2414 0.3225
0.9995
1.9532
SUM159PT
TNBC
Basal B
Ribavirin
15402.211
uM
51.66870
999.82030
0.4628 -0.6950 0.2941 0.1569
0.8782
3.0887
AU565
HER2amp
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7793.016
uM
42.57250
65.16510
-0.8497 -1.0000 2.5806 0.2359
0.9519
1.1616
HCC1806
TNBC
Basal A
2-deoxyglucose
12702.177
uM
556.93120
1000.00000
-0.1052 -0.4162 1.0348 0.1905
0.9832
1.5730
MDA-MB-361
HER2amp
Luminal
CGC-11047
Polyamine analogue
9648.026
uM
128.35510
1000.00000
-0.2701 -0.5737 0.3723 0.3304
0.7969
0.7065
MDA-MB-361
HER2amp
Luminal
CGC-11047
Polyamine analogue
7895.018
uM
202.80460
1000.00000
-0.8635 -1.0000 0.6886 0.3918
0.7644
1.2916
HCC2185
TNBC
Luminal
Ribavirin
15306.211
uM
inf
inf
0.9179 0.9179 0.0000 0.0789
0.0000
0.4935
MDA-MB-361
HER2amp
Luminal
CGC-11047
Polyamine analogue
10095.034
uM
45.56020
1000.00000
-0.6337 -0.9350 0.3414 0.4082
0.6725
0.7874
MDA-MB-361
HER2amp
Luminal
Chloroquine
12989.177
uM
0.07044
0.07617
-1.0000 -0.2394 5.0000 0.6207
0.6940
0.3765
MX1
Unknown
Unknown
Ibandronate
FDPS
10644.143
uM
70.98440
315.23990
-0.4930 -1.0000 0.7369 0.4141
0.8107
0.6221
MX1
Unknown
Unknown
Ibandronate
FDPS
12220.143
uM
51.18350
329.6960
-0.5371 -1.0000 0.5898 0.4324
0.6251
0.4532
MDA-MB-436
TNBC
Basal B
CGC-11047
Polyamine analogue
7899.018
uM
667.12150
1000.00000
0.1240 -0.0951 0.4301 0.2248
0.8264
2.0432
SUM159PT
TNBC
Basal B
TAPI-0
TACE/Collagenase
7531.096
uM
inf
inf
0.8694 0.8694 0.0000 0.0391
0.3982
3.5504
CAMA-1
HR+
Luminal
Ibandronate
FDPS
10755.143
uM
93.02980
186.9680
-0.7925 -0.8809 1.4554 0.3745
0.9695
0.9034
CAMA-1
HR+
Luminal
Ibandronate
FDPS
12070.143
uM
209.3390
252.68780
-0.7810 -0.7813 5.0000 0.2384
0.9969
0.9561
MDA-MB-436
TNBC
Basal B
CGC-11047
Polyamine analogue
7900.018
uM
inf
inf
-0.7506 -0.7506 0.0000 0.4724
0.5038
0.8304
HCC1937
TNBC
Basal A
Nelfinavir
13115.174
uM
6.86140
8.82710
-0.9981 -1.0000 4.3611 0.1920
0.9948
0.8122
MDA-MB-436
TNBC
Basal B
CGC-11047
Polyamine analogue
7902.018
uM
788.84610
1000.00000
0.1746 -0.0490 0.3938 0.2081
0.7743
1.8686
MDA-MB-157
TNBC
Basal B
Mebendazole
12632.174
uM
0.47426
1.51290
-0.7326 -0.7913 0.8179 0.5406
0.9867
0.8563
HCC1806
TNBC
Basal A
CGC-11047
Polyamine analogue
9376.026
uM
41.79070
248.34420
-0.9007 -1.0000 0.6165 0.5604
0.8770
1.6827
HCC1806
TNBC
Basal A
CGC-11047
Polyamine analogue
7830.018
uM
220.51760
382.13150
-0.9259 -0.9553 1.9432 0.4203
0.9868
1.5320